Market Place
Sourcing Support
Turnstone Biologics Corp. Reports Q4 2024 Financial Results
28 Mar 2025 //
GLOBENEWSWIRE
Turnstone Announces Plans to Explore Strategic Alternatives
04 Feb 2025 //
GLOBENEWSWIRE
Turnstone Biologics Reports Q3 2024 Financial Results & Business
12 Nov 2024 //
GLOBENEWSWIRE
Turnstone Biologics Presents TIL Therapy Data at SITC 2024
05 Nov 2024 //
GLOBENEWSWIRE
Turnstone Biologics to Lay Off 60% of Workforce, Overhaul C-Suite
11 Oct 2024 //
BIOSPACE
Turnstone Announces Strategic Restructuring to Prioritize Portfolio
11 Oct 2024 //
GLOBENEWSWIRE
Turnstone narrows cell therapy focus to `high unmet need` tumor indications
15 Aug 2024 //
FIERCE BIOTECH
Turnstone Biologics Reports Positive Data From Ph 1 Trial In Colorectal Cancer
14 Aug 2024 //
GLOBENEWSWIRE
Turnstone Biologics Reports Q2 2024 Financial Results And Business Highlights
14 Aug 2024 //
GLOBENEWSWIRE
Turnstone Bio Q1 2024 Financials, Business Highlights
13 May 2024 //
GLOBENEWSWIRE
Turnstone At BofA Securities Healthcare Conference 2024
08 May 2024 //
GLOBENEWSWIRE
Turnstone Biologics Appoints William Waddill to its Board of Directors
16 Apr 2024 //
GLOBENEWSWIRE
Turnstone Biologics Reports Fourth Quarter and Full Year 2023 Financial Results
21 Mar 2024 //
GLOBENEWSWIRE
Turnstone Biologics to Participate in Upcoming Investor Conferences
21 Feb 2024 //
GLOBENEWSWIRE
Turnstone Biologics Announces the Passing of CLO P. Joseph Campisi, Jr., Esq.
20 Feb 2024 //
GLOBENEWSWIRE
Turnstone to Participate in the Piper Sandler 35th Annual Healthcare Conference
27 Nov 2023 //
GLOBENEWSWIRE
Turnstone Biologics Corp. Reports Third Quarter 2023 Financial Results
10 Nov 2023 //
GLOBENEWSWIRE
Turnstone Presents Data Highlighting Potential for TIL Therapy in Solid Tumors
03 Nov 2023 //
GLOBENEWSWIRE
Turnstone Biologics Appointed Dr. Jeffrey S. Weber
30 Oct 2023 //
GLOBENEWSWIRE
Turnstone Biologics to Present Preclinical Data for Selected TIL Therapy
28 Sep 2023 //
GLOBENEWSWIRE
Turnstone Biologics Corp. Reports Second Quarter 2023 Financial Results
01 Sep 2023 //
GLOBENEWSWIRE
Turnstone turns fortunes around with $80M IPO haul
21 Jul 2023 //
FIERCE BIOTECH
Turnstone Biologics Corp. Announces Pricing of Upsized Initial Public Offering
21 Jul 2023 //
GLOBENEWSWIRE
Turnstone charts $75M IPO for TIL cell therapies in drumroll of biotech IPOs
17 Jul 2023 //
ENDPTS
Turnstone Bio turns to public investors to fund TIL therapies in IPO filing
14 Jun 2023 //
ENDPTS
Booted by Big Pharma, Turnstone files IPO to fund cell therapies
13 Jun 2023 //
FIERCE BIOTECH
Turnstone Biologics to Present Preclinical Data for Selected TIL Therapy at AACR
13 Apr 2023 //
BUSINESSWIRE
Turnstone Biologics Enters Agreement with the National Cancer Institute
29 Nov 2022 //
BUSINESSWIRE
Turnstone Biologics to Present Preclinical Data From Novel TIL Therapy
08 Nov 2022 //
BUSINESSWIRE
Turnstone Biologics Announces FDA Clearance of IND for TIDAL-01
31 Oct 2022 //
BUSINESSWIRE
Takeda axes clinical-stage program in $1B+ Turnstone Biologics collaboration
29 Jul 2022 //
ENDPTS
Turnstone and Moffitt Cancer Center Announce Strategic Alliance for Solid Tumors
06 Jul 2022 //
BUSINESSWIRE
2seventy bio plucks Turnstone exec Bernstein to be new CMO
15 Feb 2022 //
FIERCEBIOTECH
Turnstone Biologics Raises $80 Million Series D Financing
21 Jul 2021 //
BUSINESSWIRE
Turnstone rounds up $80M to fly immunotherapies through clinic
21 Jul 2021 //
FIERCEBIOTECH
Turnstone Biologics Raises $80 Million Series D Financing
20 Jul 2021 //
BUSINESSWIRE
Turnstone buys Myst to add tumor-infiltrating lymphocyte assets
20 Jan 2021 //
FIERCEBIOTECH
Turnstone buys Myst to add tumor-infiltrating lymphocyte assets
20 Jan 2021 //
FIERCEBIOTECH
Turnstone Biologics Announces First Patient Ph1/2 Trial Evaluating RIVAL-01
01 Dec 2020 //
BUSINESSWIRE
Turnstone Announces First Patients Enrolled in Ph 1/2 Trial RIVAL-01
01 Dec 2020 //
BUSINESSWIRE
